Valiant Laboratories Limited — Others, 24-07-2025: Copy of Newspaper Publication

Valiant Laboratories has announced a Rights Issue, offering up to 1.08 crore fully paid-up equity shares at ₹75 each, which includes a ₹65 premium. This issue aims to raise up to ₹81.47 crore. Eligible shareholders, as recorded on July 19, 2025, can subscribe at a ratio of 1 new share for every 4 shares held. The subscription period opens on July 28, 2025, and closes on August 08, 2025. Applications for this Rights Issue must be made mandatorily through the ASBA process.